Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
Bryan L. Copple, Frederic Moulin, Umesh M. Hanumegowda, Patricia E. Ganey and Robert A. Roth
Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 417-425; DOI: https://doi.org/10.1124/jpet.102.046391
Bryan L. Copple
Frederic Moulin
Umesh M. Hanumegowda
Patricia E. Ganey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 305, Issue 2
1 May 2003
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
Bryan L. Copple, Frederic Moulin, Umesh M. Hanumegowda, Patricia E. Ganey and Robert A. Roth
Journal of Pharmacology and Experimental Therapeutics May 1, 2003, 305 (2) 417-425; DOI: https://doi.org/10.1124/jpet.102.046391
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
Bryan L. Copple, Frederic Moulin, Umesh M. Hanumegowda, Patricia E. Ganey and Robert A. Roth
Journal of Pharmacology and Experimental Therapeutics May 1, 2003, 305 (2) 417-425; DOI: https://doi.org/10.1124/jpet.102.046391
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement